• Overview
  • Eligibility
  • More info
  • Locations

Pharmacokinetic, Hemodynamic and Ergogenic Assessment of a Pre-Workout Dietary Supplement (NCT03022604)

This study is assessing the effects of a pre-workout dietary supplement.
  • : C4/Generation 4
    12 grams of C4/Generation 4
    • : C450X
      12 grams of C450X
      • : Placebo
        12 grams of flavored dextrose
        Ages eligible for Study
        18 Years to 40 Years
        Genders eligible for Study
        Accepts Healthy Volunteers
        Accepts Healthy Volunteers
        Inclusion Criteria:
        • Participants must be apparently healthy males and/or females between the ages of 18 and 40
        • Participants must have at least 6 months immediate prior history of resistance training including the bench press and leg press/squat
        Exclusion Criteria:
        • Participants who have a history of treatment for metabolic disease (i.e., diabetes), hypertension, hypotension, thyroid disease, arrhythmias and/or cardiovascular disease
        • Participants who currently use any prescription medication
        • Participants who are intolerant to caffeine and/or other natural stimulants
        • Participants who are pregnant or lactating women
        • Participants who have a history of smoking
        • Participants who drink excessively (12 drinks per week)
        The purpose of this study is to examine the acute effects of a pre-workout dietary supplement at a standard dose and one that is delivered at 150% of the standard dose on energy metabolism, cardiovascular hemodynamics, blood metabolites and mental focus.
        31 May, 2015
        19 January, 2017
        A girl giving information about available additional trials.

        FindMeCure helps you find, understand and join clinical trials from all over the world.

        There are more clinical trials for your condition!